ARA-290
10mgPrecios por Volumen
Por unidad — descuentos por volumen aplicados automáticamentePrecios mayoristas disponibles para cuentas aprobadas
Acerca de ARA-290
ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from the non-erythropoietic tissue-protective structure of erythropoietin (EPO). It selectively activates the innate repair receptor (IRR), a heterodimer of the EPO receptor and the IL-3 receptor beta common chain. ARA-290 is extensively studied for neuroprotection, anti-inflammatory effects, and tissue repair without stimulating erythropoiesis.
Preguntas Frecuentes
Todos los péptidos de Signal se someten a rigurosas pruebas de terceros y tienen una pureza garantizada ≥99%. Cada lote incluye un Certificado de Análisis (COA) verificado a través del sistema de verificación blockchain de AuthentiChain.
Los pedidos realizados antes de las 12PM EST se envían el mismo día mediante logística de cadena de frío. Los productos se envían en empaques aislados con hielo seco para mantener la integridad de la temperatura. La entrega estándar es de 1 a 3 días hábiles.
Las cuentas aprobadas tienen acceso a términos de pago flexibles que incluyen NET 30, transferencia bancaria y tarjeta de crédito. Los precios basados en volumen se aplican automáticamente al momento del pago según la cantidad de su pedido.
Por supuesto. Contacte a su gerente de cuenta dedicado o escriba a info@signalpeps.co con el nombre del producto y número de lote. Los COA también están disponibles digitalmente a través de nuestra insignia de verificación AuthentiChain en cada página de producto.
Published Study Findings on ARA-290
Detailed Research & Citations
In-depth findings from peer-reviewed preclinical and clinical studies
ARA-290 (Cibinetide) is a synthetic 11-amino acid peptide derived from the tissue-protective structure of erythropoietin (EPO). It selectively activates the innate repair receptor (IRR) — a heterocomplex of the EPO receptor and IL-3 receptor beta common chain (βcR) — without stimulating erythropoiesis. ARA-290 is studied for neuroprotection, anti-inflammatory effects, metabolic regulation, and tissue repair across multiple organ systems.
Innate Repair Receptor Activation
ARA-290 selectively activates the innate repair receptor (IRR), triggering anti-apoptotic and cytoprotective signaling cascades including JAK2/STAT5, PI3K/Akt, and NF-κB modulation. This provides neuroprotection without the erythropoietic side effects of EPO.
Molecular Medicine (2008)Small Fiber Neuropathy Improvement
In a randomized, double-blind, placebo-controlled Phase II trial in sarcoidosis patients with small fiber neuropathy, ARA-290 significantly improved corneal nerve fiber density, neuropathic pain scores, and quality of life measures over 28 days of treatment.
Molecular Medicine (2012)Cytokine & Macrophage Modulation
ARA-290 reduces pro-inflammatory cytokine production (TNF-α, IL-6, IL-1β) and shifts macrophage polarization from M1 (pro-inflammatory) to M2 (reparative) phenotype, promoting tissue healing while dampening destructive inflammation.
Molecular Medicine (2008)Glycemic & Metabolic Effects
In Type 2 diabetes studies, ARA-290 improved metabolic parameters including HbA1c, cholesterol levels, and body weight. The metabolic benefits appear mediated through IRR-dependent pathways in pancreatic beta cells and adipose tissue.
Diabetes & Metabolism (2014)Myocardial Ischemia Protection
In preclinical models of myocardial ischemia-reperfusion injury, ARA-290 reduced infarct size by up to 50%, decreased cardiomyocyte apoptosis, and preserved cardiac function through IRR-mediated anti-apoptotic signaling.
Molecular Medicine (2008)Clinical Safety & Tolerability
ARA-290 has demonstrated excellent safety and tolerability across multiple Phase I and Phase II clinical trials. No erythropoietic effects, thromboembolic events, or serious adverse events related to the study drug have been reported. The most common side effects were mild injection site reactions.
Molecular Medicine (2012)View All 3 Sources
- Tissue-protective peptides derived from erythropoietin: their biology and translational potential
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss
- ARA 290, a non-erythropoietic EPO analogue, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes
All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Identidad Química
Cómo Ordenar
Tres simples pasos para acceder a péptidos de investigación premium
Solicite una Cuenta
Envíe una solicitud rápida con los datos de su empresa. Toma menos de 2 minutos.
Sea Aprobado
Nuestro equipo revisa las solicitudes en 1–2 días hábiles. Recibirá un correo una vez aprobado.
Realice su Pedido
Explore el catálogo, seleccione cantidades y pague. Los precios por volumen se aplican automáticamente.
Todos los productos son solo para investigación y uso en laboratorio. No destinados para consumo humano o animal. Solo profesionales calificados deben manejar estos productos.
